1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
ViroStatics, srl – Product Pipeline Review – 2012
http://www.aarkstore.com/reports/ViroStatics-srl-Product-Pipeline-Review-
2012-217928.html
RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml
Summary
Global Market Direct’s pharmaceuticals report, “ViroStatics, srl - Product Pipeline
Review - 2012” provides data on the ViroStatics, srl’s research and development
focus. The report includes information on current developmental pipeline, complete
with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, ViroStatics, srl’s corporate website, SEC filings, investor
presentations and featured press releases, both from ViroStatics, srl and industry-
specific third party sources, put together by Global Markets Direct’s team.
Scope
- ViroStatics, srl - Brief ViroStatics, srl overview including business description, key
information and facts, and its locations and subsidiaries.
- Review of current pipeline of ViroStatics, srl human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
2. Table of contents:
List of Tables 4
List of Figures 4
ViroStatics, srl Snapshot 5
ViroStatics, srl Overview 5
Key Information 5
Key Facts 5
ViroStatics, srl – Research and Development Overview 6
Key Therapeutic Areas 6
ViroStatics, srl – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
ViroStatics, srl – Pipeline Products Glance 10
ViroStatics, srl Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
ViroStatics, srl – Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
ViroStatics, srl – Drug Profiles 13
VS1-002 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
VS1-004 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
VS1-010 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
VS1-011 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
VS1-028 17
3. Product Description 17
Mechanism of Action 17
R&D Progress 17
VS411 18
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review&PubId=&pagenum=1
United Therapeutics Corporation – Product Pipeline Review – 2012
Vaxon Biotech – Product Pipeline Review – 2012
Versartis, Inc. – Product Pipeline Review – 2012
ViroStatics, srl – Product Pipeline Review – 2012
Viventia Biotechnologies Inc. – Product Pipeline Review – 2012
Xencor, Inc. – Product Pipeline Review – 2012
Xention Limited – Product Pipeline Review – 2012
4-Antibody AG – Product Pipeline Review – 2012
4. Archer Biosciences, Inc – Product Pipeline Review – 2012
Bio-Link – Product Pipeline Review – 2012
SWITCH Biotech LLC – Product Pipeline Review – 2012
Teikoku Pharma USA, Inc. – Product Pipeline Review – 2012
TetraLogic Pharmaceuticals – Product Pipeline Review – 2012
Tranzyme Pharma, Inc. – Product Pipeline Review – 2012
Unigene Laboratories, Inc. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
You can also request for sample page of above mention reports on
sample@aarkstore.com
For More details Plz do contact :